פנטה SL  400  טבליות במתן תת לשוני Israel - hebreo - Ministry of Health

פנטה sl 400 טבליות במתן תת לשוני

rafa laboratories ltd - fentanyl as citrate - טבליות למתן מתחת ללשון - fentanyl as citrate 400 mcg - fentanyl

פנטה SL  400  טבליות במתן תת לשוני Israel - hebreo - Ministry of Health

פנטה sl 400 טבליות במתן תת לשוני

rafa laboratories ltd - fentanyl as citrate - טבליות למתן מתחת ללשון - fentanyl as citrate 400 mcg - fentanyl

אוקסופורין 400 Israel - hebreo - Ministry of Health

אוקסופורין 400

dexcel ltd, israel - pentoxifylline - קפליות - pentoxifylline 400 mg - pentoxifylline - pentoxifylline - for the treatment of disorders of arterial and venous cirulation.

מאקליבן 400 מג  5 מל Israel - hebreo - Ministry of Health

מאקליבן 400 מג 5 מל

novartis israel ltd - amoxicillin as trihydrate; clavulanic acid as potassium - אבקה להכנת תרחיף - amoxicillin as trihydrate 400 mg / 5 ml; clavulanic acid as potassium 57 mg / 5 ml - amoxicillin - amoxicillin - for the treatment of lower respiratory tract infections, otitis media infections, sinusitis infections, acute pharyngitis, skin and soft tissues infections and urinary tract infections caused by beta-lactamase producing organisms which are susceptible to amoxycillin + potassium clavulanate and are resistant to other beta-lactam antibiotics.

אוגמנטין  תרחיף  400 מג5 מל Israel - hebreo - Ministry of Health

אוגמנטין תרחיף 400 מג5 מל

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - אבקה להכנת תרחיף - clavulanic acid as potassium salt 57 mg / 5 ml; amoxicillin as trihydrate 400 mg / 5 ml - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - otitis media, sinusitis, respiratory tract infections e.g. recurrent tonsilitis.

אטודולק אי.אר. טבע   400 מג Israel - hebreo - Ministry of Health

אטודולק אי.אר. טבע 400 מג

teva pharmaceutical industries ltd, israel - etodolac - טבליה - etodolac 400 mg - etodolac - etodolac - for the management of signs and symptoms of osteoarthritis and rehumatoid arthritis.

נורופן פורטה טבליות 400 מג Israel - hebreo - Ministry of Health

נורופן פורטה טבליות 400 מג

reckitt benckiser (near east) ltd - ibuprofen - טבליות מצופות - ibuprofen 400 mg - ibuprofen - ibuprofen - relief of mild to moderate pain, such as headache, toothache, menstrual pain, backache, muscular pain. for the relief of symptoms associated with rheumatic diseases.

טריל 400 מג CR Israel - hebreo - Ministry of Health

טריל 400 מג cr

taro pharmaceutical industries ltd - carbamazepine - טבליות בשחרור מבוקר - carbamazepine 400 mg - carbamazepine - carbamazepine - epilepsy with the following types of seizure: partial seizures with complex symptomatology ; generalised tonic-clonic seizures; mixed seizure patterns; prophylaxis and treatment of bipolar disorders..

טופיראמט טבע   400 מג Israel - hebreo - Ministry of Health

טופיראמט טבע 400 מג

teva pharmaceutical industries ltd, israel - topiramate - טבליה - topiramate 400 mg - topiramate - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.

טופיראמט טבע   400 מג Israel - hebreo - Ministry of Health

טופיראמט טבע 400 מג

teva pharmaceutical industries ltd, israel - topiramate - טבליה - topiramate 400 mg - topiramate - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.